Results 21 to 30 of about 4,714 (209)
Reproductive outcome after frozen embryo transfer with hormone replacement therapy according to luteal-phase support protocol: systematic review and network meta-analysis of randomized controlled trials. [PDF]
Ultrasound Obstet GynecolABSTRACT Objective To compare reproductive outcome between luteal‐phase support (LPS) protocols for frozen embryo transfer (FET) cycles with hormone replacement therapy (HRT). Methods A search was conducted in MEDLINE, Scopus, LILACS, EMBASE, Scielo.br, PROSPERO, CINAHL, PsycINFO, AMED, ClinicalTrials.gov, ICTRP, the Cochrane Library and conference ...
Etrusco A +11 more
europepmc +2 more sources
BMC Pregnancy and Childbirth, 2021 Background Preterm birth is a major challenge in obstetric and perinatal care. It is the leading cause of neonatal death. The primary aim of this study was to evaluate the efficacy of oral dydrogesterone on latency period in managing preterm labor.
Suparudeewan Thongchan, Vorapong Phupong
doaj +1 more source
Treatment of symptoms of the menopause: an endocrine society clinical practice guideline [PDF]
, 2015 Objective: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. Participants: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and
Davis, Susan R. +6 more
core +1 more source
RETRACTION: <b>Comparison of the Effect of Dydrogesterone and Natural Micronized Progesterone for Luteal-Phase Support in Assisted Reproductive Technology Cycles: A Single-Blind Randomized Clinical Trial Study</b>. [PDF]
Health Sci RepRETRACTION: M. Atarieh, M. Javadian, Z. Basirat, M. Kashifard, S. Yazdani, H. Adib‐Rad, M. Abdollahzade‐Delavar, and H. Gholinia, Health Science Reports 7, no. 8 (2024): e2296. https://doi.org/10.1002/hsr2.2296. The above article, published online on 08 August 2024 in Wiley Online Library (wileyonlinelibrary.com), and has been retracted by agreement ...
europepmc +2 more sources
Hormone replacement therapy [PDF]
, 2012 Martha Hickey, Jane Elliott, Sonia Louise ...
Davison, S., Elliott, C., Hickey, M.
core +2 more sources
Advanced Biomedical Research, 2018 Background: The aim of this study was to evaluate the effect of dydrogesterone in the outcome of idiopathic intrauterine growth restriction (IUGR). Materials and Methods: It is a double-blind randomized control clinical trial study that was done in ...
Elaheh Zarean +2 more
doaj +1 more source
Reproductive Medicine and Biology, 2021 Purpose To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real‐world setting. Methods The post‐marketing study involved 15 sites in Japan.
Jo Kitawaki +3 more
doaj +1 more source
Endocrinology, Diabetes & Metabolism Case Reports, 2023 A 31-year-old woman with complete androgen insensitivity syndrome (CAIS) experienced breast volume fluctuations during biphasic hormone replacement therapy consisting of estradiol and cyclical dydrogesterone, a progestin.
Benthe A M Dijkman +3 more
doaj +1 more source
Prescribing patterns in premenstrual syndrome [PDF]
, 2002 Background Over 300 therapies have been proposed for premenstrual syndrome. To date there has been only one survey conducted in the UK of PMS treatments prescribed by GPs, a questionnaire-based study by the National Association of Premenstrual Syndrome ...
Katrina M Wyatt +27 more
core +2 more sources
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy [PDF]
, 2014 The rate of hypertension increases after menopause. Whether estrogen and progesterone deficiency associated with menopause play a role in determining a worst blood pressure (BP) control is still controversial.
Cagnacci, Angelo, Cannoletta, Marianna
core +2 more sources